CTIMS provides information support, statistical support, and data management for extramural/intergroup and expanded access trials sponsored by CTEP.
NCI Central Institutional reduces the administrative burden on local IRBs and investigators while continuing a high level of protection for human research participants.
The Melanoma Research Foundation Breakthrough Consortium (MRFBC) is a Melanoma Research Foundation-supported clinical trials group founded in 2010.
The National MDS Study will build a resource that will enable scientists to conduct research to improve the way MDS is diagnosed and how it is treated
National Cancer Institute-supported clinical trials group was founded in 1995 to support innovative trials for AIDS-associated malignancies.